the United States. The etiology of gastroesophageal reflux disease (GERD) is clearly linked to the prolonged contact of acidic gastric contents with the esophageal luminal surface. However, what remains largely undefined is why certain individuals with GERD experience mild "heartburn" symptoms with minimal histological inflammation, whereas other individuals develop complications including chronic inflammation, ulceration, stricture formation, metaplastic transformation into Barrett's esophagus, as well as adenocarcinoma (33) . Host esophageal defense factors that ultimately determine the degree of mucosal injury in response to esophageal acid exposure must be invoked. The investigation of mucosal defense in esophageal disease has been limited, with a majority of work focusing on damage to tight junctions and loss of epithelial integrity in response to acid (30, 31) . Attempts to characterize the molecular and cellular basis for esophageal inflammation have remained limited, largely the result of the relative inaccessibility of in vitro esophageal cell populations for investigation.
Within the histological descriptions characterizing GERD, there are classic features of gastrointestinal inflammation. Selective recruitment of circulating eosinophils are frequently identified in mild-moderate esophagitis, and in ulcerative esophagitis, the most severe manifestation of GERD, infiltration of polymorphonuclear leukocytes from the microcirculation into the esophageal tissue, can be detected in Ͼ80% of endoscopic specimens (18) . Given our current understanding of endothelial-leukocyte interaction in the local recruitment of select immunocyte populations, the accumulation of immune cells in the esophagus points to a central and active role for the microvascular endothelium in GERD. Other clinical and histological features of GERD include local microvascular hemorrhage, edema, and ulcerations, all manifestations of inflammatory processes in the gastrointestinal tract. Thus if we consider GERD an inflammatory process, defining the cellular and molecular mechanisms in-volved in esophageal mucosal defense and inflammation becomes an essential objective in understanding GERD.
Overwhelming evidence exists demonstrating differentiation and specialization of the microvascular endothelium in organs and tissues, including marked endothelial cell (EC) heterogeneity among different adult human tissues (7, 10, 29) . Specialized EC function also exists in the intestinal microcirculation, in which the mucosal addressin CAM-1 (MAdCAM-1) plays a major role in specific leukocyte homing to the mucosal immune compartment (2, 19, 46) . In addition, EC subsets derived from different vascular beds are heterogeneous in responsiveness to cytokines and their expression of cell adhesion molecules (CAMs) and secretory products (14, 25, 34, 35, 42) .
Therefore, to understand the role of tissue-specific EC in esophageal homeostasis and disease, we isolated microvascular EC from resected human esophagus surgical specimens. With this novel cell population available for in vitro studies, we characterized the morphology, phenotype, response to classic inflammatory stimulants, and cellular activators unique to the esophagus and defined intracellular signaling cascades in esophageal EC activation. We contrasted these findings in esophageal cells with microvascular EC isolated from the lower human gastrointestinal tract (human intestinal microvascular EC; HIMEC). Our preliminary investigation demonstrates that human esophageal microvascular ECs (HEMEC), although possessing classic vascular markers, are a unique EC population, phenotypically and functionally distinct from HIMEC.
MATERIALS AND METHODS
Patients. Normal esophageal full-thickness specimens were obtained from discarded cadaveric tissue from transplant donors as well as normal margins from patients undergoing esophagectomy. Normal colonic and ileal resection specimens were used from patients undergoing scheduled surgical bowel resection. The use of human tissues for isolation of EC was approved by the Institutional Review Board of The Medical College of Wisconsin.
Reagents. EC growth supplement (ECGS) was from Upstate Biotechnology (Lake Placid, NY). RPMI 1640 medium and FBS were obtained from BioWhittaker (Walkersville, MD). Human plasma fibronectin was purchased from Chemicon International (Temecula, CA). MCDB-131 medium, porcine heparin, and penicillin/streptomycin/fungizone (PSF) were from Sigma (St. Louis, MO). Unless otherwise indicated, all other chemicals used in this study were purchased from Sigma.
Cell culture. HEMEC were isolated by using a technique previously described for the generation of HIMEC cultures (5) . In brief, mucosal strips dissected from esophageal fullthickness tissue were washed, minced, and digested in collagenase type II solution (2 mg/ml; Worthington Biochemical, Freehold, NJ). EC were mechanically expressed and plated onto fibronectin-coated tissue culture dishes in growth medium [MCDB-131 medium supplemented with 20% (vol/vol) FBS and ECGS, porcine heparin (130 g/ml), and 2.5% (vol/ vol) PSF solution]. After 7-10 days of culture, microvascular EC clusters were physically isolated, and a pure culture was obtained. HEMEC cultures were recognized by microscopic morphological features, expression of factor VIII-associated antigen, and modified lipoprotein uptake by using 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethyl-indocarbocyanine perchlorate-labeled acetylated LDL (Dil-ac-LDL; Biomedical Technology, Stoughton, MA) by fluorescence microscopy (51) . All experiments were carried out by using primary EC cultures between passages 8 and 14. U-937 cells were obtained from American Type Culture Collection (Manassas, VA) and maintained in culture with RPMI 1640 medium containing 5% (vol/vol) FBS. Neutrophils from healthy donors were purified by dextran sedimentation as described previously (37) . Cell viability and purity was Ն95% as assessed by Trypan blue exclusion and DiffQuik staining (Baxter Scientific, McGraw, IL).
Activation and pharmacological modulation of HEMEC. TNF-␣ (100 U/ml), LPS (1 g/ml; LPS from Escherichia coli 0111:B4; Sigma), IL-1␤ (100 U/ml), IL-4 (20 ng/ml), IL-5 (5 ng/ml), and IL-6 (100 U/ml) were added to EC monolayers for specified time periods. All cytokines and chemokines used in this study were purchased from R&D Systems (Minneapolis, MN). The contribution of signal transduction pathways to HEMEC activation and gene expression were defined by using specific inhibitors, including p38 MAPK inhibitor SB-203580 (10 g/ml; Calbiochem, San Diego, CA); p42/44 MAPK inhibitor PD-98059 (7 g/ml; Calbiochem); the antioxidant curcumin (1-20 M; Sigma), and the inhibitors of NF-B activation Bay 11 (5 M; Biomol Research Laboratories, Plymouth Meeting, PA) and SN-50 (18 M, Biomol Research Laboratories). EC were incubated in acidified growth medium (pH 4.5 by the addition of HCl) for specified time periods where indicated. N-iminoethyl-L-lysine (L-NIL; 20 M, Alexis Biochemicals, San Diego, CA) was added to EC monolayers at the time of induction of a selective inhibitor of inducible nitric oxide (NO) synthase (iNOS).
Chemokine ELISA. Supernatants from cultured EC were harvested after different stimulation time points or from untreated cells, respectively. Secretion of the chemokines interleukin 8 (IL-8) and eotaxin from unstimulated and stimulated HEMEC and HIMEC were assessed by using commercially available ELISA kits (R&D Systems). Recombinant human IL-8 and eotaxin were used to calculate a standard curve and served as a positive control, respectively. Unconditioned growth medium was used as a negative control. All conditions were assessed in triplicate.
Characterization of EC by immunofluorescence staining. Monolayers of EC were grown on fibronectin-coated coverslips for immunofluorescence staining. After cold methanol fixation and blocking with 5% BSA in PBS with Ca 2ϩ and Mg 2ϩ , monolayers were then incubated with primary antibodies for 1 h at room temperature. EC were rinsed three times in PBS before incubation with biotinylated anti-species-specific secondary antibodies for 1 h. Cells were then incubated with streptavidin FITC for 1 h in the dark. After rinsing an additional three times, immunofluorescence detection was performed with a fluorescence microscope (Olympus BX-40) and an Olympus PM-20 camera with fixed shutter speed. Primary antibodies against claudin-1, zonula occludens (ZO)-1, ZO-2, and occludin were obtained from Zymed Laboratories (South San Francisco, CA). Primary antibodies against platelet endothelial CAM-11 (PECAM-1), vascular endothelial (VE)-cadherin, ICAM-2, and P-selectin (CD62P) were from R&D Systems, whereas antibodies against von Willebrand factor were from DAKO (Glostrup, Denmark). All secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA), and FITC streptavidin was from Pierce (Rockford, IL).
Assessment of CAM surface expression. Surface expression of CAM was performed by using radioactive immunoassay (RIA) as described earlier (4, 38) . EC monolayers were assessed unstimulated or after activation. Mouse monoclonal antibodies (5 g/ml) recognizing human E-selectin, ICAM-1, and VCAM-1 (R&D Systems) were used for CAM detection. After incubation with primary antibodies at 4°C, monolayers were rinsed and incubated with goat anti-mouse biotinylated FabЈ fragment (Jackson ImmunoResearch Laboratories, West Grove, PA). Bound secondary antibody was detected with 125 I-labeled streptavidin (80 Ci/ml; Amersham Pharmacia Biotech, Arlington Heights, IL). EC monolayers were lysed with 1.0% (vol/vol) Triton X-100 in PBS (pH 7.4; BioWhittaker), and radioactivity was quantified in a gamma counter. Data from triplicate wells were expressed as the mean of 125 I-labeled streptavidin bound [counts per min (cpm)/well]. Control experiments using a nonspecific monoclonal antibody (mouse IgG; Sigma) were performed in parallel at equal concentrations and incubation conditions.
Static and dynamic leukocyte adhesion assays. Static U-937 adhesion to HEMEC was measured as described previously (4, 38) . After 24 h of activation, EC monolayers were rinsed and U-937 cells (10 6 /ml) were cocultured on endothelial monolayers and allowed to adhere at 37°C in a 5% CO2 incubator. After 1 h, nonadherent cells were removed and plates were gently washed 3 times with PBS. Monolayers were stained by using a modified Wright's stain (DiffQuik; Baxter Scientific), and adherent leukocytes were counted in 10 random high-power fields (magnification, ϫ20) by using an ocular grid. Adhesion was expressed as number of adherent leukocytes per square millimeter. In addition, EC-leukocyte interactions were assessed by using low shear stress flow adhesion assay as previously described (27, 38) . EC monolayers were analyzed directly or after stimulation with a combination of TNF-␣ (100 U/ml) and LPS (1 g/ml) in a lowshear-stress flow chamber. U-937 cells or neutrophils (1 ϫ 10 6 per ml of growth medium) were flowing over EC monolayers at 1 dyn/cm 2 , and adhesion was recorded by using a charge-coupled device camera attached to an inverted tissue culture microscope for 5 min. Data were analyzed by counting the number of adherent leukocytes (rolling plus static adhesion) over 10 random high-power fields by using a grid, and adhesion was expressed as the number of adherent leukocytes per high-power field (magnification, ϫ200).
Flow cytometry. Unstimulated and stimulated HEMEC were trypsinized and resuspended in growth medium. After two washes with ice-cold Hanks' balanced salt solution (pH 7.4; BioWhittaker), cells were resuspended in FACS buffer [PBS containing 2% (vol/vol) FBS, 1% (wt/vol) BSA, and 0.05% (wt/vol) NaN3]. Staining was performed by using anti-VCAM-1 antibodies (R&D Systems). Cells were washed in FACS buffer and incubated with FITC-labeled goat-anti mouse IgG (Santa Cruz Biotechnology). After being washed, cells were resuspended in 1% (wt/vol) paraformaldehyde (Fisher Scientific, Pittsburgh, PA) in PBS and analyzed by using FACScan (Becton Dickinson, Mountain View, CA). Matched isotype IgG antibodies were included as negative controls. Results are expressed as arbitrary fluorescence units vs. unstimulated HEMEC.
RNA extraction and semiquantitative RT-PCR. iNOS gene expression was assessed in unstimulated and activated confluent cultures of HEMEC with or without pharmacological inhibitors. Endothelial cells were stimulated with a combination of 100 U/ml TNF-␣ (R&D Systems) and 1 g/ml LPS (Sigma) or IL-1␤ (100 U/ml) ϩ TNF-␣ (100 U/ml) for 6 h at 37°C. Total RNA was extracted by using RNAzol B (Teltest, Friendswood, TX) and quantitated by optical density. Total RNA (1 g) was reverse transcribed by using SuperScript II RT (GIBCO-BRL, Grand Island, NY) in a total reaction volume of 20 l. Reverse-transcription product (1 l; cDNA) was PCR amplified by using Ampli-Taq DNA polymerase (Perkin Elmer, Norwalk, CT) and 0.5 l each of 10 M iNOS forward and reverse primers. In the iNOS reaction, ␤-actin primers were included in the reaction as an internal control for the efficiency of the RT and the amount of RNA used in the RT-PCR. The PCR cycle consisted of a denaturation step (94°C, 1 min), an annealing step (60°C, 1 min), and an elongation step (72°C, 1.5 min) with a total of 35 cycles, followed by an additional extension step (72°C, 7 min). The primer sequences and PCR product sizes were as follows: iNOS, 5Ј-TCT TGG TCA AAG CTG TGC TC-3Ј (forward) and 5Ј-CAT TGC CAA ACC TAC TGG TC-3Ј (reverse), 237 bp; and ␤-actin (25 cycles) 5Ј-CCA GAG CAA GAG AGG CAT CC-3Ј (forward) and 5Ј-CTG TGG TGG TGA AGC TGT AG-3Ј (reverse), 436 bp, respectively. PCR products were run on 1% agarose gels, stained with 0.5 g/ml of ethidium bromide, visualized under UV light, and photographed. MAdCAM-1 gene expression was assessed in activated HEMEC [TNF-␣, IL-1␤, IL-6 (100 U/ml), IL-5 (15 ng/ml), or LPS (1 g/ml)] for 18 h, respectively. Total RNA was extracted and reverse transcribed as described above. Briefly, 1 l of cDNA product was used per PCR reaction in a total volume of 40 l containing 1.5 mM MgCl 2, 0.2 mM dNTP mix, 0.5 mM primer 5Ј-CCC CTG TGA AAG CAA AAT AGC-3Ј (forward) and 5Ј-AGG TTT ATT TGC CAA AGC CTC-3Ј (reverse) (352 bp), and 1 unit of Taq polymerase. Cycle conditions were 94°C for 1 min, 58°C for 1 min, and 72°C for 1 min (32 cycles). PCR products were visualized and described as above. Control reactions were run by using ␤-actin primers for 25 cycles as described above.
SDS-PAGE and Western blot analysis.
Gel electrophoresis and Western blot analysis was performed as described earlier (38, 39) . In brief, HEMEC unstimulated or after stimulation were lysed in lysis buffer (in mM: 50 Tris ⅐ HCl, pH 7.4, 2 EDTA, 2 EGTA, 75 NaCl, 25 NaF, 25 ␤-glycerophosphate, 1 Na3VO4, 1 Na2MoO4, 1 PMSF, and 1% Nonidet P-40 and 5 g/ml each of leupeptin, aprotinin, and pepstatin) on ice. An equal volume of SDS treatment buffer [125 mM Tris ⅐ HCl, pH 6.8, 4% (wt/vol) SDS, 20% (vol/vol) glycerol, 10% (vol/vol) 2 ␤-mercaptoethanol] was added to the cell lysate, and samples were boiled. Equal amounts of protein were separated by SDS-PAGE and transferred to nitrocellulose membranes (38, 39) . The membranes were blocked and incubated with specific MAPK antibodies [p42/44 MAPK, p38 MAPK, and JNK; phosphorylated and nonphosphorylated, respectively (Cell Signaling, New England Biolabs, Beverly, MA) or phosphotyrosine antibodies (Upstate Biotechnology)]. Immunodetection of bound primary antibody was performed by horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescensce (Amersham Pharmacia Biotech, Arlington Heights, IL).
For MAdCAM-1 immunoprecipitation, cells were lysed in buffer containing [in mM: 10 Tris ⅐ HCl (pH 7.6), 2 EDTA, 100 NaCl, and 1 sodium vanadate, with 1% Triton X-100 and protease inhibitors]. After 60 min of incubation on ice, cell debris was removed by centrifugation (10,000 g, 4°C, 10 min), and supernatants were collected. Total protein (160 g) was incubated with 0.5 g of MAdCAM-1 monoclonal antibody (Bender Medsystems, Vienna, Austria) for 1 h at 4°C, then 20 l of protein G-agarose (Santa Cruz Biotechnology) was added and incubated at 4°C with gentle rotation overnight. After centrifugation at 1,000 g for 5 min, pellets were washed with PBS 4 times. Then pellets were resuspended in 30 l of SDS treatment buffer, boiled for 5 min, and analyzed as described above by using MAdCAM-1 monoclonal antibody (0.5 g/ml).
JNK activity assay. JNK activity was assayed by using a nonradioactive JNK activity assay kit (Cell Signaling). Briefly, 250 g of cell lysates were incubated with 20 l of resuspended c-Jun fusion protein beads overnight at 4°C with gentle agitation. After being washed, the pellet was incubated with the supplied kinase buffer supplemented with 100 M ATP for 30 min at 30°C. The reaction was then terminated by the addition of SDS treatment buffer, and samples were analyzed by Western blot analysis by using phospho-c-Jun antibody (Ser 63 ). Nuclear protein extraction and gel electromobility shift assay. Nuclear protein extracts were prepared from HEMEC as described previously (38, 41) . In brief, nuclear extracts were incubated with 2 g/l poly(dI-dC) and 32 P-end-labeled double-stranded synthetic desoxyoligonucleotide probe (for NF-B: 5Ј-GCC CGG GGA GGA TTC CTG GGC CCC-3Ј), and the labeled DNA was purified on push columns (Bio-Rad, Hercules, CA). Protein-DNA complexes were then resolved in polyacrylamide gels for 2 h at room temperature in Trisacetate buffer (pH 7.5). Dried gels were exposed to X-ray film to detect NF-B nuclear translocation overnight at Ϫ70°C.
Immunolocalization of NF-B p65 subunit. HEMEC were cultured on glass coverslips and stimulated as indicated in RESULTS for 3 h at 37°C. Cells were fixed and permeabilized with ice-cold methanol and blocked with 5% BSA (wt/vol) in PBS for 1 h. The p65 was immunolocalized by using anti-p65 antibody followed by incubation with a biotinylated secondary antibody (both from Santa Cruz Biotechnology) and fluoroscein isothiocyanate-streptavidin (Pierce). Slides were mounted and visualized by using a fluorescence microscope (Olympus BX-40).
Histological analysis. Full-thickness esophageal tissue was fixed in 4% (wt/vol) paraformaldehyde in PBS, saturated in 20% (wt/vol) sucrose in PBS, and embedded in optimum cutting temperature compound (Sakura, Osaka, Japan). Frozen sections (6 m) were prepared and stained by using a cell and tissue staining kit (R&D Systems) and mouse monoclonal anti-human antibodies (VCAM-1, ICAM-1, E-selectin; R&D Systems) or mouse IgG as a negative control, respectively. After immunodetection using diaminobenzidine, sections were counterstained in Mayer's hematoxylin and mounted. Positive staining is visible as a dark-brown precipitate. In parallel experiments, esophageal full-thickness tissue was paraffin embedded and stained with hematoxylineosin according to standard protocols. Factor VIII-associated antigen antibody (Sigma) staining was used to confirm microvessels in tissue sections.
Analysis of data. Statistical analysis was performed by using StatView 4.51 and SuperANOVA software for the Macintosh (Abacus Concepts, Berkeley, CA). When single comparisons were made, Student's t-tests were used, applying paired or unpaired analysis as appropriate. When multiple comparisons between groups were performed, one-way or two-way ANOVA was used as appropriate followed by the Student-Newman-Keuls test. P Յ 0.05 was considered statistically significant.
RESULTS

Morphological and phenotypic characterization of HEMEC.
The human esophagus is a highly vascularized structure, with a rich microvascular bed present within the submucosal stroma beneath the muscularis mucosa. Figure 1 , A and B demonstrates the esophageal microvessels used to generate the HEMEC iso- Fig. 1 . A and B: human esophageal microvasculature in vivo. Light microscopy of paraffin-embedded full-thickness normal esophageal tissue stained with hematoxylin and eosin demonstrates abundant esophageal microvessels (arrowheads) located in the submucosa (S). Esophageal microvessels are located in close proximity to the basal layer of the squamous epithelium (E). Human esophageal microvascular endothelial cell (EC) (HEMEC) cultures are obtained from these microvessels. L, lumen; CM, circular muscle layer; original magnification, ϫ100 (A) and ϫ400 (B). C: morphological appearance of cultured HEMEC. Phase contrast microscopy of cultured HEMEC on fibronectin-coated plate. Although a typical endothelial "cobblestone" morphology is notable in the majority of the culture, there are additional "spindle cells," a feature not typical of human microvascular endothelial cells derived from skin and intestine (not shown). Original magnification, ϫ200. Continued lates. There were a total of six individual HEMEC cultures generated during the study period used in the following experiments. HEMEC cultures were routinely expanded for 2-3 mo reaching passage 16, and an individual culture was maintained as long as passage 18. HEMEC stored in liquid nitrogen [10% dimethylsulfoxide (vol/vol) in FBS] were recultured without loss of function or viability. As assessed by phase contrast microscopy, confluent HEMEC monolayers isolated from histologically normal esophageal mucosa assume a characteristic "cobblestone" appearance morphologically distinct from that of gastrointestinal fibroblasts or smooth muscle cells. Interestingly, HEMEC displayed a slightly different morphology compared with HIMEC in which, in addition to the classic cobblestone appearance, a "spindle cell" morphology frequently emerged from clusters of EC (Fig. 1C) . EC possess receptors for modified serum lipoproteins and readily uptake these substances in vivo and in vitro (28, 36, 51) . The ability of HEMEC to internalize acetylated human LDL was assessed in vitro by using Dil-ac-LDL. After 4 h, a marked accumulation of Dil-ac-LDL was observed within HEMEC (Fig. 1D) but not in parallel cultures of human esophageal fibroblasts or gastrointestinal smooth muscle cells (not shown). Having demonstrated that HEMEC may demonstrate a spindle cell morphology, their ability to readily uptake Dil-ac-LDL proves that a mesenchymal or fibroblast-like morphology can be a normal feature of cultured esophageal microvascular EC. To further define the endothelial origin of HEMEC, additional experiments were per- Endothelial characterization of HEMEC monolayers was performed by using fluorescence and immunofluorescence microscopy. HEMEC Dil-ac-LDL uptake was demonstrated as speckled cytoplasmic fluorescence. This is a characteristic feature of endothelial cells, which confirms that cells with both a "cobblestone" as well as a "spindle" morphology are endothelial in origin. Original magnification, ϫ200. Immunofluorescence detection of claudin-1, ICAM-2, occludin, platelet endothelial cell adhesion molecule-1 (PECAM-1), ZO-1, ZO-2, and vascular endothelial (VE)-cadherin demonstrated surface expression on HEMEC, which clustered at the cell-cell junctions (original magnification, ϫ200). Immunofluorescence detection of von Willebrand factor showed intracellular cytoplasmic speckled pattern, which again confirms the endothelial origin of HEMEC (original magnification, ϫ200).
formed by using immunofluorescence staining. HEMEC expressed claudin-1, ICAM-2, occludin, PE-CAM-1, ZO-1, ZO-2, VE-cadherin, and von Willebrand factor (Fig. 1D) .
Differential secretion of chemokines in HEMEC. To investigate the differential production of secretory products in HEMEC, ELISAs of cell culture supernatants were performed to detect secreted IL-8, the prototypic CXC chemokine associated with acute inflammation, and eotaxin, an eosinophil-specific chemotactic factor. Although eosinophil recruitment is commonly associated with esophageal inflammation, no eotaxin was detectable in stimulated (TNF-␣/LPS, IL-1␤) and unstimulated HEMEC isolates from three individual transplant donors (data not shown). Interestingly, this chemokine is abundantly secreted by human esophageal smooth muscle cells (D. G. Binion, unpublished observation). IL-8 secretion in HEMEC and HIMEC was potently induced by TNF-␣/LPS (Fig. 2) . Compared with HIMEC, stimulated HEMEC constitutively expressed significantly less IL-8 as assessed for multiple time points (6, 12, 24 h) in culture.
Modulated expression of MAdCAM-1 in HEMEC. We then assessed the ability of HEMEC to express MAd-CAM-1, an adhesion molecule critical for leukocyte trafficking and immune homeostasis in human intestine (43) . Unstimulated HEMEC did not express detectable amounts of MAdCAM-1 mRNA using specific primers in a semiquantitative RT-PCR analysis. However, marked upregulation of MAdCAM-1 transcripts was detectable after stimulation with TNF-␣ and IL-1␤ (100 U/ml each), two prototypical proinflammatory cytokines. Stimulation with IL-5, a cytokine associated with early esophagitis (26) , and IL-6, an acute-phase proinflammatory cytokine, did not result in detectable MAdCAM-1 transcripts (Fig. 3A, top) . Amplification of ␤-actin transcripts served as an internal control (Fig.  3A, bottom) . Western blot analysis of immunoprecipitated MAdCAM-1 protein demonstrates a low-level constitutive expression of MAdCAM-1 in unstimulated HEMEC, and there was a marked upregulation of MAdCAM-1 on stimulation with TNF-␣/IL-1␤ (Fig.  3B ). HEMEC stimulation with IL-6 did not lead to enhanced MAdCAM-1 expression compared with unstimulated HEMEC. Finally, stimulation with gramnegative LPS also strongly enhanced the protein expression of MAdCAM-1 in HEMEC (Fig. 3B) .
Differential adhesion molecule expression in HEMEC and HIMEC. EC express CAM on their cell surface, a physiological phenomenon tightly regulated by cytokines and inflammatory activators (17, 23, 48, 49) . We investigated the regulated expression of CAM in HEMEC in response to dual inflammatory stimulation with TNF-␣/LPS. This potent, proinflammatory activation by cytokine and LPS is known to induce cellular activation and enhanced CAM expression in HIMEC (5). We assayed the modulated expression of ICAM-1, VCAM-1, and E-selectin by RIA in HEMEC and HIMEC, unstimulated or after TNF-␣/LPS or IL-1␤ activation for 6 h. TNF-␣/LPS stimulation demonstrating the expression of all three CAMs were markedly and significantly enhanced (Fig. 4A) , with highest con- Each condition was assessed in triplicate, and data are expressed as mean chemokine concentration Ϯ SE (pg/ml). * P Ͻ 0.05. Monoclonal antibodies against ICAM-1 (C), E-selectin (D), VCAM-1 (E), and positive isotype mouse IgG control (F) were used to detect CAM expression in endothelial submucosal microvessels. Factor VIII-associated antigen staining in paired sections was used for identification of endothelial cells (data not shown). Antibody staining is visible as a dark brown precipitate. There was positive staining for ICAM-1 and VCAM-1, and to a lesser extent E-selectin, in normal esophageal microvessels (arrowheads, Fig. C-F; original magnification, ϫ400). Additional experiments were performed on esophageal sections that were not counterstained to demonstrate the specificity of imunostaining for VCAM-1 compared with isotype control (Fig. G and  H) . Representative images from triplicate experiments are shown. stitutive and modulated expression of ICAM-1, respectively. HEMEC expressed consistently higher levels of VCAM-1 vs. HIMEC when compared head-to-head after 6-h stimulation (P Ͻ 0.05). HEMEC expression of VCAM-1 was felt to be clinically relevant, because this CAM has been demonstrated to play a critical role in the recruitment of eosinophils, which are frequently identified in esophagitis and GERD (18) .
HEMEC demonstrated low-level expression of Eselectin or VCAM-1 in response to IL-1␤, unlike HIMEC, which greatly increase expression of all three of these CAMs in response to this cytokine (Fig. 4B) . The lack of VCAM-1 induction by IL-1␤ in HEMEC is similar to previous findings in dermal microvascular EC, in which IL-1␤ failed to induce VCAM-1 after in vivo injection into the skin of human volunteers (16) . Additional experiments were carried out with IL-4 and IL-5, cytokines implicated in the etiopathogenesis of esophagitis and GERD. When administrated either alone or in combination, these cytokines did not alter CAM expression above baseline. When IL-4 and IL-5 were used in combination with TNF-␣/LPS, there was no further increase in CAM expression in HEMEC (data not shown).
We then analyzed the expression of the CAMs ICAM-1, VCAM-1, and E-selectin in intact microvessels from esophageal tissues (Fig. 4, C-H) . With the use of frozen sections of freshly resected esophageal tissues, we detected all three of these CAMs in the esophageal microvessels, confirming that the expression of these molecules in HEMEC is relevant to the in vivo situation.
Leukocyte adhesion and functional assessment of NO generation. Cultured EC exposed to cytokines will dramatically increase their capacity to bind leukocytes after in vitro activation (3, 6) . HEMEC were incubated for 24 h with and without activators (TNF-␣/LPS or TNF-␣/IL-1␤) and then cocultured with U-937 cells, a monocyte-like cell line, for 1 h in a static adhesion assay. Under unstimulated conditions, only low numbers of U-937 cells adhered to HEMEC (Fig. 5, A 
-E).
After stimulation with TNF-␣/LPS, there was a marked increase in U-937 cell binding (Fig. 5C) . In these experiments, we also evaluated whether a selective iNOS inhibitor, L-NIL, would alter HEMEC adhesion for leukocytes. We have previously shown that NO produced by the iNOS pathway plays a critical downregulatory role in HIMEC activation and leukocyte adhesion (5). Interestingly, pretreatment of HEMEC with 20 M L-NIL, a dose selective for iNOS inhibition, significantly increased baseline adhesion of U-937 cells, a finding not present in HIMEC (5). This suggests that HEMEC exhibit constitutive iNOS expression, which differs from HIMEC in which L-NIL exerted no effect on leukocyte adhesion in unstimulated HIMECs. When we assessed the effect of TNF-␣/LPS activation with selective iNOS inhibition by using L-NIL, there was a similar significant increase in leukocyte binding, suggesting a regulatory role of iNOS in activated HEMEC similar to HIMEC. These data are summarized in Fig. 5E , in which adherent leukocytes are expressed per millimeter squared of HEMEC surface, and iNOS inhibition resulted in significant increases in leukocyte adhesion in all conditions tested (P Ͻ 0.05).
In addition to evaluating the activation of HEMEC in response to classic proinflammatory cytokines and LPS, we performed experiments to determine the effect of cytokines specifically implicated in esophagitis and GERD, such as IL-4 and IL-5. These cytokines either alone or in combination failed to induce alterations in U-937 adhesion to HEMEC above baseline in both static and flow adhesion assays (data not shown).
iNOS expression in HEMEC. To assess the role of iNOS, a major downregulatory modulator in the inflammatory activation of human microvascular ECs, mRNA and protein levels of iNOS were determined in HEMEC stimulated with TNF-␣/LPS by semiquantitative RT-PCR (Fig. 6A) and Western blot analysis (Fig.  6B ) by using human iNOS-specific antibodies. It is of interest that both approaches revealed constitutive low-level expression of iNOS in unstimulated HEMEC, a physiological feature not present in unstimulated HIMEC (5) . After TNF-␣/LPS stimulation for 6 h, there was a marked increase in the expression of iNOS in HEMEC (Fig. 6, A and B) . This increase was blocked by pretreatment of HEMEC with curcumin (Fig. 6, A and  B) and the specific NF-B inhibitors Bay 11 and SN-50 (Fig. 6A) . These data suggest a regulatory role for iNOS in unstimulated as well as TNF-␣/IL-1␤-and TNF-␣/LPS-activated HEMEC and support the functional data demonstrated in Fig. 5 .
MAPK signaling in HEMEC activation. We then sought to characterize the signaling mechanisms involved in TNF-␣/LPS activation of HEMEC. Phosphorylation/dephosphorylation of protein kinases plays a key role in the regulation of cell activation, and we have shown that TNF-␣/LPS stimulation of HEMEC led to tyrosine phosphorylation of several proteins identified by immunoblotting of cell lysates by using an anti-phosphotyrosine antibody (Fig. 7A) . These tyrosine phosphorylated proteins included proteins of molecular mass 42, 57, 76, 85, 116, and 130 kDa. We sought to determine the identity of these phosphoproteins and whether physiological activation in response to acidic pH would also induce activation of these signaling cascades.
Previously, we (38) demonstrated that TNF-␣/LPS activation of HIMEC resulted in activation in serine/ threonine MAPK, including p42/44 MAPK (ERK), p38 MAPK, and JNK, which are known to play a central role in the inflammatory activation of EC. In this study, we show phosphorylation of all three MAPK members in response to TNF-␣/LPS-activated HEMEC (Fig. 7B) . To study physiological stimuli linked to esophageal inflammation and GERD, we performed experiments examining the effect of IL-4 and IL-5 on MAPK activation in HEMEC. Our results indicate that IL-4 and IL-5 neither alone nor in combination have any effect on MAPK activation in HEMEC (data not shown). These data suggest that alternative pathways are involved in HEMEC activation, and we focused investigation on VCAM-1 expression and acid pH-induced activation of HEMEC.
JNK activation by TNF-␣/LPS and acid exposure in HEMEC.
As revealed by a recent investigation, acid exposure significantly enhances phosphorylation of MAP kinases in esophageal epithelium, thus potentially contributing to carcinogenesis in Barrett's esophagus (47) . To determine whether acid exposure leads to activation of these signaling pathways in HEMEC, cells were exposed for multiple time points with acidified growth medium (pH 4.5), and immunodetection of phosphorylated MAP kinases was subsequently performed in EC lysates. Although normally not exposed to acidic pH, esophageal ECs might become activated by acid contact, presuming a disturbed mucosal squamous epithelial barrier, as seen in erosive reflux esophagitis and peptic esophageal ulceration. When HEMEC were exposed to acidic pH, there was a significant and rapid activation of JNK and to a lesser extent p42/44 MAPK (Fig. 7, C and E) and no p38 MAPK phosphorylation and activation (data not shown). Of interest, the phosphorylation of p42/44 MAPK was less rapid and less pronounced compared with JNK phosphorylation. Although an increase in phospho-p42/44 MAPK was detected at 10 and 15 min after acid exposure, there was no increase in kinase activity when functional assessment of this MAPK protein was performed (Fig. 7E) . The increase in phospho-ERK may represent autophosphorylation of this kinase, which will not result in increased functional activity. These experiments suggest that exposure of esophageal microvascular ECs to acidic pH will result in selective activation of JNK. HEMEC stimulation consisted of either IL-1␤/TNF-␣ (100 U/ml of each) or TNF-␣ (100 U/ml)/LPS (1 mg/ml) for 24 h before the 1-h U-937 coculture. L-NIL caused a twofold increase in leukocyte binding in the unstimulated as well as the activated HEMEC. Each experiment was performed with a distinct HEMEC cell line derived from 3 different patients (n ϭ 3 total experiments, performed in duplicate; data are expressed as means Ϯ SE; *P Ͻ 0.05).
Kinase activity of JNK in HEMEC.
A kinase activity assay of TNF-␣/LPS and acid-activated HEMEC demonstrated an increased JNK activity (Fig. 7D) . Pharmacological pretreatment before HEMEC activation revealed that the antioxidant curcumin and NF-B inhibitor Bay 11 abolished JNK activity (Fig. 7D) . Wortmannin, a phosphatidylinositol 3-kinase inhibitor, partially inhibited the activation of JNK in HEMEC, suggesting a potential contribution of this pathway in HEMEC.
Dose-dependent inhibition of VCAM-1 expression by curcumin. Inflammatory activation of HEMEC with cytokines and LPS resulted in a rapid phosphorylation of JNK completely inhibited by curcumin and Bay 11. We then focused our attention on the link between JNK activation and the expression of VCAM-1 in HEMEC. Increasing dosages of curcumin pretreatment demonstrated a dose-dependent inhibition of VCAM-1 expression in response to activation with TNF-␣/LPS by using both cell surface RIA (Fig. 8A) as well as flow cytometry (Fig. 8B) . To correlate the inhibitory effect of curcumin on JNK activation and CAM expression, we performed experiments by using this compound on HEMEC in the low-shear-stress flow adhesion assay. At 20 M concentration, curcumin completely inhibited the enhanced adhesion of both U-937 cells as well as freshly isolated human peripheral blood neutrophils to TNF-␣/LPS-activated HEMEC (Fig. 8C) . PD-98059, the selective p42/44 MAPK inhibitor, and SB-203580, the specific inhibitor of p38 MAPK, failed to inhibit VCAM-1 expression in HEMEC, again demonstrating the importance of the JNK pathway in the expression of this CAM (data not shown).
NF-B activation in HEMEC. Activation of EC in response to cytokines may ultimately result in activation of the transcription factor NF-B and gene transcription including the expression of CAMs (E-selectin, ICAM-1, VCAM-1) as well as iNOS. To further assess whether the transcription factor NF-B was involved in TNF-␣/LPS and acid activation of HEMEC, NF-B electrophoretic mobility shift assays were performed. Activation of NF-B from HEMEC nuclear extracts was detected after 3 h of TNF-␣/LPS or pH 4.5 stimulation that was blocked by curcumin (Fig. 9) . Antibody against p65 subunit of NF-B resulted in supershift, confirming NF-B activation. This result was further supported by immunofluorescence staining of nuclear localization of p65 (Rel A), a member of the NF-B protein family. In unstimulated HEMEC, p65 was detected in the cytoplasm of the cells (Fig. 10A ). After stimulation with TNF-␣/LPS for 3 h, p65 was translocated into the nucleus (Fig. 10B) . These results clearly indicate a mechanistic role for NF-B in the response to inflammatory stimuli in HEMEC.
DISCUSSION
The present study is the first systematic investigation of microvascular endothelium from the human esophagus, with a specific focus on the molecular and cellular mechanisms that underlie inflammatory activation of these cells. There were six notable findings that emerged from this work, specifically: 1) this was the first description of HEMEC isolation and culture; 2) characterization of HEMEC revealed that they are a microvascular endothelial population that are phenotypically and functionally distinct from HIMEC; 3) HEMEC express MAdCAM-1; 4) HEMEC and intact human esophageal microvessels express the CAMs ICAM-1, VCAM-1, and E-selectin; 5) HEMEC express unique patterns of the iNOS compared with HIMEC; and 6) cytokine and LPS activation of HEMEC involves NF-B and MAPKs, and exposure to acidic pH will result in selective activation of JNK.
There has been limited investigation of the microvasculature and EC function in the pathophysiology of esophageal inflammation and GERD. Sbarbati et al. (45) directly addressed the involvement of the microvasculature in esophagitis by using ultrastructural analysis with transmission electron microscopy. In 30 patients with documented esophagitis but no Barrett's metaplasia, they found signs of microangiopathy in all individuals ranging from interrupted to duplicated or thickened basal laminae in the esophageal microvessels. In areas of Barrett's columnar metaplasia, the microvasculature showed an ectatic lumen and a thin basal lamina without duplications or interruptions. They concluded that microangiopathy is associated with epithelial damage in GERD.
Endothelial cells lining the microvasculature are now appreciated to play a central "gatekeeper" role in inflammation through their ability to recruit circulating immune cells into tissues (15, 24) . Microvascular endothelial activation and adhesion of circulating immune cells is an early and rate-limiting step in the initiation and maintenance of the inflammatory re- sponse. We focused our investigation on the contribution of HEMEC to esophageal inflammation and leukocyte recruitment.
Leukocyte recruitment into the esophagus during GERD is the direct result of endothelial activation. The selective recruitment of eosinophils in esophagitis, particularly pediatric esophagitis, has been explored by numerous investigators. Early reports by Brown (9) and Winter (51) found that eosinophil recruitment into the esophageal mucosa was a characteristic feature of esophagitis, in adults as well as children. In their analysis, eosinophil infiltration of the epithelium was found in 52% of patients and was the only histological feature of esophagitis in 23% of confirmed cases. The state of activation of esophageal eosinophils was evaluated by Justinich (20) by using an ultrastructural electron microscopic analysis. In 12 patients with esophagitis, activated eosinophils were identified crossing the microvascular endothelium and migrating into the mucosa, a finding not present in normal controls. Previous investigation has suggested that specific cytokines and chemokines will mediate the leukocyte trafficking associated with esophagitis, specifically IL-4, IL-5, and eotaxin. IL-4, a cytokine associated with the progression of esophagitis into metaplastic transformation (Barrett's esophagus) (11) , and IL-5, a key cytokine implicated in the pathogenesis of human and animal models of esophagitis, as well as eosinophil trafficking (26) , failed to exert a direct effect on HEMEC during the early time periods we studied. Likewise, investigation of chemokine expression patterns from HEMEC did not demonstrate production of eotaxin, the CC chemokine implicated in the selective recruitment of circulating eosinophils. These data suggest that local eosinophil recruitment in esophagitis and GERD may result from eotaxin production from stromal cells in the esophagus that do not include the microvascular endothelium.
HEMEC did demonstrate unique patterns of leukocyte recruitment and CAM expression in response to cytokine and bacterial activators. High levels of VCAM-1 were demonstrated in HEMEC compared with HIMEC. Likewise, tissue expression of VCAM-1 in esophageal microvessels was demonstrated. The EC adhesion molecules VCAM-1, ICAM-1 (1), and P-selectin but not E-selectin (40) mediate eosinophil tethering and binding. Previous reports have suggested that endothelial expression of VCAM-1 interacting with its cognate ligand, VLA-4 (␣ 4 ␤ 1 -integrin) expressed on eosinophils, will mediate trafficking of this leukocyte population (44) , which may be attenuated by smallmolecule ␣ 4 ␤ 1 -antagonists (22) . These data suggest that VCAM-1 expression by HEMEC may play a significant role in selective leukocyte recruitment into the esophagus.
Lymphocyte trafficking is mediated by interactions between homing receptors on the lymphocyte and vascular addressins expressed on specific endothelium that are controlled by a variety of inflammatory mediators. Lymphocyte homing to mucosal surfaces including Peyer's patches and the lamina propria of the intestine is critically dependent on a single-chain 60 kDa glycoprotein adhesion molecule, the mucosal vascular addressin or MAdCAM-1 (2). MAdCAM-1 is expressed on ECs within the mesenteric lymph nodes, the lamina propria of both the small and large intestine, and the mammary gland during lactation. During chronic gut inflammation in IL-10 knockout mice there is a 10-to 11-fold increase in MAdCAM-1 expression (21). Increased MAdCAM-1 has been detected in the colonic lamina propria microvessels in mice with hapten-induced colitis, colitis secondary to IL-2 deficiency, and severe combined immunodeficient (SCID) mice reconstituted with CD4 ϩ CD45RB ϩ T cells. Antibodies directed against either MAdCAM-1 or its leukocyte ligand ␣ 4 ␤ 7 have blocked the development of chronic inflammation in the SCID RB45 reconstitution model of colitis, demonstrating the central role of this leukocyte addressin in the development of an inflammatory bowel disease (IBD) lesion. In human IBD (both Crohn's disease and ulcerative colitis), MAdCAM-1 expression has been shown to be dramatically increased compared with control tissues (8) . This important role for MAdCAM-1/␣ 4 ␤ 7 -integrin interaction in chronic gut inflammation has led to a successful pilot trial of anti-␣ 4 antibody therapy in IBD patients. Because of the central role of MAdCAM-1 in normal intestinal immune homeostasis, as well as chronic gut inflammation in IBD, we sought to determine whether this molecule would also be expressed in the upper gut and the esophageal microvasculature. HEMEC expressed MAdCAM-1 at the mRNA and protein levels that increased in response to inflammatory activation, and this is the first report of esophageal localization of MAdCAM-1. This suggests the possibility of similar mechanisms of endothelial-leukocyte interaction occurring in severe refractory esophagitis and as seen in IBD.
Our laboratory has previously characterized an important regulatory role for iNOS-derived NO in the regulation of inflammatory activation of HIMEC (38) . Similarly, HEMEC also expressed iNOS that would downregulate leukocyte binding. However, distinctly different from HIMEC, HEMEC expressed constitutive iNOS that decreased basal leukocyte adhesion to this endothelial population. The physiological implication of this finding suggests that esophageal microvessels will recruit lower numbers of leukocytes, which is true in routine histological evaluation of the esophagus compared with the small and large bowel.
Esophagitis and GERD are presently believed to result from the prolonged contact of acidic gastric refluxate with the esophageal mucosal lining. Investigation of the cellular and molecular mechanisms that follow acid exposure have centered around reparative and proliferative effects after acid, because the most dreaded complication of GERD is metaplasatic transformation into Barrett's esophagus, a precursor lesion to adenocarcinoma of the esophagus. Acidic pH has been demonstrated to promote cell growth in explants of Barrett's tissue maintained in organ culture. In these experiments, acidic pH resulted in an increase in proliferation as measured by tritiated thymidine uptake and expression of cyclooxygenase-2, an antiapoptotic protein (12, 13, 32) . In more recent experiments focused on identifying intracellular signaling mechanisms that would undergo activation in response to acid, Souza and colleagues (47) characterized the activation of MAPK pathways in response to acid in SEG-1 cells, a Barrett's adenocarcinoma-derived esophageal epithelial cell line. In these experiments, transient exposure of transformed epithelial cells to acidic pH resulted in cell proliferation, a decrease in apoptosis, which corresponded with activation of p38 MAPK, ERK, and a delayed activation of JNK. Increased proliferation was abolished by inhibition of p38 MAPK or JNK, whereas inhibition of apoptosis was linked to ERK activity. Souza et al. (47) correlated these in vitro studies with biopsies from Barrett's esophagus patients, taken before and after 3 min of esophageal acid perfusion. These in vitro analyses demonstrated a significant functional increase in p38 MAPK activity and a trend in the increase in JNK activity. Our studies focused on the effect of acidic pH on the activation of primary esophageal EC, and also characterized MAPK family member activation (JNK) as well as NF-B. Because HEMEC are a primary cell line derived from adult differentiated tissues, they were extremely sensitive to acid stimulation. Sustained acid treatment (Ͼ6 h) that is necessary to define CAM expression and enhanced leukocyte binding would result in significant cell death. Because of this outcome, we were unable to carry out experiments for CAM expression and leukocyte binding in response to prolonged acid exposure in HEMEC. However, short-term acid exposure, performed in the characterization of signal transduction cascades did not result in cell toxicity. Our studies suggest that the MAPK cascades will also be involved in the inflammatory activation of nonimmune cell populations in the esophagus, leading to chronic inflammation and leukocyte infiltration that accompanies esophagitis and GERD.
In summary, we have characterized HEMEC at the morphological, phenotypic, and functional levels. MAd-CAM-1 as well as unique patterns of CAM expression were demonstrated in HEMEC. The NO biology of HEMEC appears unique, because constitutive iNOS is expressed in this EC population. HEMEC undergo activation in response to cytokines and LPS as well as acidic pH exposure. Future use of HEMEC will help to define unique patterns of leukocyte recruitment and mechanisms of inflammation in the human esophagus. 
